Share this post:

Donald McNeil’s article covers the criteria used to analyse companies’ contributions to preventing the spread of bacteria that are resistant to antibiotics. It also focuses on the importance of having new antibiotics in development.

“GSK and Johnson & Johnson are the best of the big pharmaceutical companies at tackling the growing “superbug” threat, according to an index released Tuesday at the World Economic Forum in Davos, Switzerland.”

 

Read full article